Biochemistry, Genetics and Molecular Biology
MicroRNA
66%
Cancer Cell
39%
RNA
35%
RNA-binding Protein
32%
Steroid Receptor
32%
Sorafenib
21%
Transactivation
20%
Binding Protein
18%
Nuclear Receptor Coregulators
17%
Epidermal Growth Factor Receptor
16%
Growth Factor Receptor Inhibitor
16%
SOX9
16%
HES1
16%
ID1
16%
Notch
16%
Cancer Stem Cell
16%
Transcription Factors
16%
Erlotinib
16%
Fluorouracil
16%
Carcinogenesis
16%
Aurora Kinase
16%
Nuclear Receptor Corepressor
16%
Stem-Loop
16%
Protein Complex
16%
RNA-induced Silencing Complex
16%
Dicer
16%
Drug Resistance
16%
Tyrosine Kinase Inhibitor
16%
Cell Migration
15%
Nuclear Receptor
14%
Tumor Suppressor Protein
13%
Cell Proliferation
12%
Colony Formation
7%
Tissue Microarray
6%
Promoter Region
5%
Protein Kinase B
5%
Inhibitor of Differentiation 1
5%
Inhibitor of Differentiation 3
5%
Zinc Finger Transcription Factor
5%
Cell Dedifferentiation
5%
CRISPR/Cas9
5%
Proto Oncogene
5%
Small Hairpin RNA
5%
Colon Mucosa
5%
Transcriptome
5%
YAP1
5%
Medicine and Dentistry
microRNA
100%
Prostate Cancer
32%
Hepatocellular Carcinoma
32%
Cancer Cell
28%
Cell Proliferation
21%
Sorafenib
20%
Carisoprodol
17%
Erlotinib
16%
Head and Neck Cancer
16%
Metastatic Carcinoma
16%
Melanoma Cell
16%
Fluorouracil
16%
Aurora Kinase Inhibitor
16%
Disintegrin
16%
Carcinogenesis
16%
Notch
16%
Growth Disorder
16%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Coregulators
16%
Cell Nucleus Receptor
16%
RNA Binding Protein
16%
Steroid Receptor
16%
Transcription Factors
16%
RNA Induced Silencing Complex
16%
Metalloproteinase
16%
Transactivation
16%
Colorectal Carcinoma
16%
Protein Complex
16%
Drug Resistance
16%
Tyrosine-Kinase Inhibitor
12%
Neoplasm
11%
Tumor Suppressor Protein
9%
Melanoma
8%
Cell Migration
8%
Colony Formation
7%
In Vitro
7%
Immunohistochemistry
7%
Tissue Microarray
6%
Epidermal Growth Factor Receptor
6%
Epithelial Mesenchymal Transition
6%
Lenvatinib
6%
Colon Mucosa
5%
Small Interfering RNA
5%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Prostate Cancer
48%
Liver Cell Carcinoma
32%
Tumor Suppressor Protein
23%
Sorafenib
19%
RNA Induced Silencing Complex
16%
Cell Nucleus Receptor
16%
Nephroblastoma
16%
Aurora Kinase Inhibitor
16%
Disintegrin
16%
Growth Disorder
16%
Steroid Receptor
16%
Transcription Factors
16%
Metalloproteinase
16%
RNA Binding Protein
16%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Fluorouracil
16%
Head and Neck Cancer
16%
Carcinogenesis
16%
Erlotinib
16%
Dicer
16%
Colorectal Carcinoma
16%
Drug Resistance
16%
Neoplasm
14%
Protein Tyrosine Kinase Inhibitor
10%
Malignant Neoplasm
9%
Small Interfering RNA
6%
Epidermal Growth Factor Receptor
5%
Lenvatinib
5%